Are nucleos(t)ide analogues effective against severe outcomes in COVID-19 and hepatitis B virus coinfection?

Gupse Adali Pinar Gokcen Fatih Guzelbulut Ayca Gokcen Degirmenci Salturk Nihat Buğra Ağaoğlu Busra Unal Hamdi Levent Doganay Kamil Özdil

Published in: Hepatology forum (2021)

HBV infection was not associated with mortality in patients with COVID-19, and it seems that NUC treatment for HBV infection might have an antiviral effect on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Keyphrases

hepatitis b virus
respiratory syndrome coronavirus
sars cov
coronavirus disease
liver failure
risk factors
molecular docking
cardiovascular disease
type diabetes
coronary artery disease